Haring-Layton MarDee bought DARE
January 30, 2026 · Form 4 insider transaction
Haring-Layton MarDee bought 49,000 shares of Daré Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
49,000
Price
$0.00
Total value
N/A
InsiderHaring-Layton MarDee
Role—
CompanyDaré Bioscience, Inc. (DARE)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 2, 2026
Shares owned after49,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.